This winter, the United States experienced a notable shift in the landscape of respiratory illnesses, with influenza surpassing COVID-19 in both infections and hospitalizations. This marks a significant change from recent years, where COVID-19 dominated public health concerns. Health officials are closely monitoring the situation, as the virulence of both viruses appears to be increasing, raising questions about whether this pattern will continue in future seasons.
The surge in flu cases has placed a considerable strain on healthcare systems across the nation. At least 7.5 million Americans have gotten sick with the flu since October, leading to 19,053 hospitalizations as of December 20, 2025 – nearly doubling from the 9,944 reported the week prior . Approximately 3,100 deaths have been attributed to the flu this season, including five pediatric fatalities . The current influenza season, which began in October, has already seen at least 24 million cases, 310,000 hospitalizations, and 13,000 deaths, including 57 children .
The Rise of Influenza and Similar Virulence to COVID-19
The shift in dominance from COVID-19 to influenza is a complex phenomenon. Experts suggest that waning immunity from previous COVID-19 infections and vaccinations, coupled with lower vaccination rates for influenza, may be contributing factors. A new variant of Influenza A, known as H3N2, has been dubbed the “super flu” due to its rapid spread . The Washington Post reported in March 2026 that flu has grow as virulent as COVID-19 .
Several states are experiencing particularly high levels of flu activity. As of December 20, 2025, flu activity was categorized as “high” or “very high” in 32 states and jurisdictions . States including New York, New Jersey, South Carolina, Louisiana, and Colorado were at the highest end of the range, while California, Nevada, Missouri, Arkansas, Alabama, and Florida were newly reporting high levels . Ten states and New York City are experiencing the highest levels of flu activity, according to the CDC .
Preparing for Future Respiratory Virus Seasons
Health officials are emphasizing the importance of preventive measures, including vaccination, to mitigate the impact of both influenza and COVID-19. The CDC provides weekly updates on influenza surveillance, monitoring visits for respiratory illness that includes fever plus a cough or sore throat . These reports are crucial for healthcare providers to recognize infection patterns and prepare for potential increases in patient volume . Medical distributors and health systems are also focusing on strategic equipment planning to ensure readiness for late-season surges .
Dr. Daniel Kuritzkes, a senior infectious disease physician at Mass General Brigham in Boston, noted that the current trajectory of the flu curve indicates a sharp increase with no signs of peaking or leveling off . He anticipates continued increases in flu cases for several weeks, potentially not leveling off until the end of January or February.
Looking ahead, it remains to be seen whether the pattern of influenza surpassing COVID-19 will become a consistent trend. Ongoing surveillance, research into viral evolution, and continued public health efforts will be crucial in understanding and responding to future respiratory virus seasons. The interplay between immunity, viral variants, and vaccination rates will likely shape the landscape of these illnesses in the years to come.
Share your thoughts on this evolving situation in the comments below, and please share this article with your network to help spread awareness.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
